MICROSURGICAL INNOVATIONS, INC.
Tacrolimus-eluting nerve guidance conduit for enhanced regeneration in critical-sized peripheral nerve injuries
Tacrolimus-eluting nerve guidance conduit for enhanced regeneration in critical-sized peripheral nerve injuries is a funding opportunity from MICROSURGICAL INNOVATIONS, INC., up to 1005546, closing April 30, 2027.
Apr 30, 2027
(273d left)Overview
PROJECT SUMMARY/ABSTRACT This project aims to commercialize a state-of-the-art FK506-eluting, biodegradable nerve conduit designed to improve the treatment and outcomes of peripheral nerve injuries dramatically. Peripheral nerve injuries, which can result from a variety of causes, including accidents and surgical…